Nephron Sc Inc: Drug Recall

Recall #D-0175-2023 · 01/13/2023

Class II: Risk

Recall Details

Recall Number: D-0175-2023
Classification: Class II
Product Type: Drug
Recalling Firm: Nephron Sc Inc
Status: Terminated
Date Initiated: 01/13/2023
Location: West Columbia, SC, United States
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 387,000 vials

Reason for Recall

Short Fill

Product Description

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Distribution Pattern

Nationwide within the United States including Puerto Rico. Guatamala

Other Recalls by Nephron Sc Inc

Class II: Risk 02/23/2023

CGMP Deviations: Potential product carryover.
Class II: Risk 01/13/2023

Short Fill
Class II: Risk 01/12/2023

CGMP Deviations: potential for trace amounts of product carryover.
Class II: Risk 01/12/2023

CGMP Deviations: potential for trace amounts of product carryover.
Class II: Risk 08/10/2022

cGMP Deviations: deviations leading to potential cross-contamination.

View all recalls by Nephron Sc Inc →

Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.